Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-004355-20Phase 4Completed
Phase 4, randomised trial of neomycin and metronidazole in rectal cancer and rectal disease (not a specific disease; refers to a group of diseases affecting the rectum) (2 arms), sponsored by Helsinki University Hospital. Primary endpoint: Complications within 30 days from the surgery. Started May 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-004355-20.